possibility of an SAA inducer and have found that macrophages make an SAA inducer in response to LPS. These findings demonstrate the mechanism by which LPS produces increased SAA concentrations and lay a logical framework for explaining how chronic inflammation may result in amyloidosis.
Materials and Methods
Mice. Female C3H/HeN mice, aged 6-10 wk, were obtained from the Division of Research Resources, National Institutes of Health, Bethesda, Md. Female and male C3H/HeJ mice, aged 4-8 wk, were obtained from The Jackson Laboratory, Bar Harbor, Maine. No significant sex differences have been observed in the acute phase response of C3H or other mice to endotoxin although males tend to fight and elevated SAA concentrations have been observed in these injured mice (K. McAdam and J. Sipe, unpublished results). Serum containing SAA inducer was obtained by bleeding C3H/HeN mice from the orbital plexus between 2 and 2.5 h after the i.p. administration of K235 LPS (1 /ag in 0.2 ml of pyrogen-free saline). Control serum was obtained from untreated or saline-injected animals as specified.
Adoptive transfer of bone marrow cells was carried out with C3H/HeJ or C3H/HeN bone marrow cells prepared from 12-wk-old mice by the method of Michalek and co-workers (Suzanne Michalek, personal communication). The method consists of grinding femurs and tibias in RPMI-1640 medium, filtering the suspended cells through gauze to remove small pieces of bone, and suspending the cells at a concentration of 10S/ml for injection. Chimeric mice were tested 5 wk after adoptive transfer for their ability to produce SAA inducer.
Reagents. Endotoxin was prepared from E. coli K235 by the phenol-water extraction procedure of Mclntire et al. (21) . The dose response curve for SAA induction in C3H/HeN and C3H/HeJ mice was similar to that reported earlier (13) . With the present preparation of LPS, <5/tg/ml SAA was induced by 5 #g LPS after 18 h in C3H/HeJ mice, whereas ~ 1,000/Lg/ml SAA was induced in C3H/HeN mice. Sterile thioglycollate broth was obtained from the National Institutes of Health Media Unit. RPMI-1640 medium (Grand Island Biological Company, Grand Island, N. Y.) was supplemented with penicillin (100 U/ml), streptomycin (100/Lg/ml), glutamine (2 mM), and 15 mM Hepes buffer.
Production of SAA Inducer by LPS-Treated Cell Cultures. Mice were injected with 3 ml of sterile thioglycollate i.p. and 6 d later the induced peritoneal exudate cells were collected by peritoneal lavage with pyrogen free saline (Abbott Diagnostics, Diagnostic Products, Chicago, Ilk). These cells were routinely found to be >90% macrophages by differential staining of cytospin preparations (Shandown Southern Products Limited, Runcorn, Cheshire, England). Adherent cells were obtained by incubation of 2 X 106 peritoneal exudate cells in serum-free RPMI in TC-24 culture dishes (Costar, Data Packaging, Cambridge, Mass.) at 37°C for 3 h after which the nonadherent cells were removed by washing. Adherent cell monolayers contained >98% macrophages. In some experiments, the nonadherent cells were not removed. Spleen cell preparations were prepared by teasing the spleens and resuspending the washed cells to 2 X 106 spleen cells/ml in serum-free RPMI. Cells were incubated with or without 10/.tg/ml LPS.
SAA Measurements. SAA concentration was estimated in serum obtained by bleeding animals from the orbital plexus at various times after injection of serum from LPS-treated C3H/HeN or C3H/HeJ mice, or medium from LPS-treated cell cultures. A 10-/LI aliquot of serum to be tested for SAA was added to 500/A of 10% formic acid and incubated for 24 h at 56°C. Either the entire dilution, or aliquots of it, was lyophilized and resuspended in casein barbital buffer, and the SAA concentration was estimated according to the capacity of the sample to compete with I2SI-AA binding by immobilized anti-AA antibodies (22) . Each dilution of sample was assayed in duplicate on at least two separate occasions. At least 10 samples were employed to normalize the data for immunoassays carried out on separate occasions. The SAA concentration for individual animals was averaged for the multiple determinations, and the arithmetic mean and SEM determined. The SEM is indicated after each mean concentration of SAA. Occasionally, as is indicated in the legends, a single value was discarded if its value was greater than the mean plus 1.5 times the SD of the mean. 
Results

Detection of SAA Inducer in Serum of LPS-Treated Mice.
The process of SAA induction in C3H/HeN mice by LPS has been characterized previously (13, 16) . Initially there is a 2-3 h latent period before the SAA concentration begins to rise; then there is a period of synthesis during which the SAA concentration increases exponentially to almost 1,000/~g/mi by 16-24 h-after treatment with 5 #g or more LPS; and lastly there is a deinduction period during which the SAA concentration returns to preinduction levels by 48 h after LPS treatment. C3H/HeJ mice show a diminished SAA response to all forms of endotoxin and in particular to K235 phenol-extracted LPS. At the peak of the acute phase response, 5/lg of K235 LPS elicits <5/.tg/ml SAA in C3H/HeJ mice as compared with 1,000/~g/ml in C3H/HeN mice (13) .
In the present study it was found that serum from C3H/HeN mice obtained 2.5 h after administration of LPS, which is at the end of the latent period before the normally observed exponential rise in SAA concentration, was capable of stimulating SAA synthesis by C3H/HeJ mice. This data is shown in Fig. 1 . The SAA concentration in C3H/HeJ sera was observed to increase between 1.5 and 2.5 h after i.p. injection of 0.2 ml of serum from C3H/HeN mice treated with 1 /~g of LPS, and rose to ~100 /lg/ml by 5.5 h (Fig. la) . The same quantity of LPS did not stimulate significant quantities of SAA in C3H/HeJ mice ( SAA inducer is present in serum of C3H/HeN mice at maximal concentrations by ~90 min after administration of 1/tg LPS, and has begun to diminish by the end of the latent period of SAA induction, at the beginning of the exponential rise in SAA concentration (Fig. 2) . The time course is similar for induction of SAA inducer whether the i.v. or i.p. route of administration of LPS is employed. Injection of LPS intravenously leads to the appearance of higher concentrations of both SAA inducer and SAA (Fig 2) as compared with the i.p. route. This may be due to a dose response effect resulting from effectively higher concentrations of LPS and LPS-derived SAA inducer in the blood stream when the i.v. route is employed. However, it has been experimentally convenient to employ the i.p. route for the preparation of large quantities of SAA inducer.
The time course for induction of SAA by serum SAA inducer is much different than the profile typically obtained for the acute phase SAA response to LPS (Fig. 3) . When SAA is induced in C3H/HeJ mice with 0.2 ml of latent period serum (SAA < 10 ~g/ml) from C3H/HeN mice treated with 1 ~g of LPS, the SAA concentration is 30-90/~g/ml (Figs. 1 and 3 ) by 4 h after administration, and this is ~50% of the maximum concentration observed (Fig. 3) . In contrast, the acute phase SAA response of C3H/HeN mice to LPS itself is marked by a 1,000-fold increase in SAA concentration which has reached only 5-10% of its maximum value at 4 h (16). This is consistent with the premise that SAA is not induced in C3H/HeJ mice by passively transferred LPS. Furthermore, the data shown in Figs. 3 and 4 indicate that 0.2 ml of serum from C3H/HeN mice given 1 #g of LPS stimulated up to 100-fold greater SAA concentrations in C3H/HeJ mice than did 1 btg of LPS itself.
The dose dependence of SAA induction by serum SAA inducer is shown in Fig. 4 . The minimum vol of serum that can be feasibly employed appears to be 0.2 ml. Note The serum was collected from the pooled blood and immediately administered i.p. to six C3H/HeJ mice (12 wk old) for each specified volume. The SAA concentration for the pool was subsequently determined to be 10 #g/ml. 601 that 0.5 ml of serum was >100-fold more effective than LPS in stimulating SAA, when volume factors are taken into account.
Evidence for the Production of SAA Inducer by Macrophages. The resistance of C3H/HeJ mice to mount an acute phase SAA response to LPS appears to be caused by a lymphoid cell defect in the ability to respond to LPS by formation of the SAA inducer. Evidence for this was obtained using chimeric animals (Table I) . Pooled serum from 10 C3H/HeJ mice to which had been adoptively transferred bone marrow cells from C3H/HeN mice, induced a mean SAA concentration of 11 #g/ml, whereas 0.2 ml pooled serum from 10 mice in each of the four groups above was administered i.p. to C3H/HeJ female mice (5 wk old). The arithmetic mean and its SE was obtained from all 7 animals in group 1, for 7 of 9 animals for group 2, for 9 of 10 animals in group 3, and for all 9 animals in group 4. The SAA concentration of the administered serum was <2 #g/ml in all cases. Further evidence for the derivation of SAA inducer from bone marrow-derived cells comes from the data shown in Fig. 5 . Thioglycollate-induced peritoneal macrophages were incubated for varying lengths of time with 10 #g/ml LPS, and the culture medium was harvested, filter sterilized, and injected i.p. into C3H/HeJ mice. About 30% of the maximal amount of SAA inducer was detected in the culture medium by 6 h, indicating that the in vitro SAA inducer is potentially the same one which is acting in vivo. Furthermore, it can be seen that 1 ml of the culture medium from 2 X 106 peritoneal cells is as effective as 0.2 ml of serum from C3H/HeN mice given 1 /lg of LPS. * Culture medium was obtained as described in Materials and Methods. 1 ml was injected into seven or eight animals. The mean and its SE were computed from the number of animals indicated in the numerator. Culture medium was obtained as described in Materials and Methods. 1 ml was injected into six animals, and the mean and its SE were computed for all six animals in each case.
The macrophage origin of LPS-derived SAA inducer is further supported by the data shown in Table II . Washed, adherent peritoneal exudate cells were as effective in producing SAA inducer in response to LPS as was the entire cell population. In contrast, LPS-stimulated spleen cells from C3H/HeN mice did not make SAA inducer, nor did LPS-stimulated macrophages from C3H/HeJ mice (Table III) .
Discussion
We have shown that the endotoxin-induced acute phase SAA response involves two distinct populations of cells. We have detected a factor that appears in serum during the initial or "latent" part of the acute phase SAA response to endotoxin which can stimulate SAA synthesis in mice that are resistant to the acute phase stimulus itself. The idea, put forth by Rosenstreich and McAdam (19) , that a lymphoid cell may be responsible for initiating the SAA response to endotoxin is supported by the evidence presented herein that chimeric C3H/HeJ mice reconstituted with C3H/HeN bone marrow cells are capable of producing the SAA inducing factor in response to LPS. It appears likely that the SAA inducer arises from the interaction of LPS with macrophages, in view of the observation that SAA inducer can be obtained in vitro by endotoxin stimulation of thioglycollate-induced C3H/HeN macrophages but not from a population of LPS-treated C3H/HeN spleen cells that contains <10% mac-rophages. SAA inducer begins to appear in culture medium within the first 6 h of LPS treatment; thus, it is possible that the in vitro and in vivo inducers are the same. Preliminary results (J. Sipe, unpublished observations) indicate that the serum SAA inducer is a trypsin-sensitive macromolecule, the activity of which is markedly reduced by incubation of latent period serum at 37°C.
The possibility that the SAA inducing factors observed both in vivo and in vitro might arise artifactually by transfer of a precursor of SAA would seem to be ruled out by the fact that the SAA concentrations of both latent period serum and culture medium were minimal. As formic acid denaturation is always employed for the antigenic assay of SAA, it seems unlikely that nonimmunoreactive AA determinants are being transferred.
At present, little can be said about the chemical nature of SAA inducer. Our present understanding of the origin of acute phase reactants (23) would suggest that SAA inducer arises from macrophage injury by endotoxin and that SAA inducer subsequently stimulates the SAA synthesizing cell. It is tacitly assumed in this concept that the inducer is a cell product rather than a product of the inflammatory stimulus itself. This seems reasonable, in view of the wide range of agents which can induce acute phase reactants such as SAA and CRP and in view of the fact that localized inflammation can bring about a strong SAA response (12; A. Weinblatt and J. Sipe, unpublished observations). However, it may be that C3H/HeN macrophages alter K235 (ph) LPS so that it is now stimulatory for C3H/HeJ mice. Such a mechanism has been postulated for induction of B-cell mitogenesis in C3H/HeJ mice by LPS (24) . The previously mentioned lability of SAA inducer in serum would seem to rule out this possibility.
The identification of an endotoxin-induced mediator of SAA biosynthesis raises many interesting questions about its role in the synthesis of other acute phase reactants and inducible liver proteins: Does the SAA inducing factor elicit other acute phase reactants such as CRP (12) and do the numerous inflammatory agents which stimulate an SAA response act via a common mediator or by different ones? Biochemical studies are currently in progress to isolate and characterize the endotoxin-produced mediator of SAA induction from LPS-stimulated macrophage culture supernates. The in vitro induction of SAA by an inflammatory agent, such as endotoxin, has not yet been described; clearly, the chemical characterization of SAA inducer will be facilitated by an in vitro assay.
The existence of this newly recognized mediator of the inflammatory response also raises many interesting questions as to its role in amyloidogenesis. It may be that the same mediator acting on different cell populations induces AA polypeptides of different amino acid sequence; or that various mediators, which can induce different AA polypeptides, are produced according to the nature of the inflammatory agents. Perhaps an individual mediator of SAA induction may have a preferential affinity for the hepatocyte, but when present in high concentrations due to prolonged inflammation it may stimulate other tissues, such as spleen, to synthesize amyloid A protein (3, 25, 26) . Thus, the chemistry and concentration of the mediator may be important in the pathogenesis of amyloidosis as well as factors which have already been recognized, such as microheterogeneity of the AA polypeptide (25) and proteolytic processing of the AA polypeptide (27) .
The required intervention .of an LPS-sensitive lymphocyte or macrophage in the production of SAA suggests a plausible mechanism by which chronic inflammation induces amyloidosis. The isolation and characterization of this SAA inducer may greatly facilitate studies on the pathogenesis of amyloid0sis. Finally it will be interesting to learn whether the SAA inducer is newly synthesized in response to LPS or is released by macrophages involved in the processing of LPS, and to learn if any other biological activities reside in the SAA inducer. SAA inducer appears to be distinct from interferon because interferon was not detectable in latent period serum, and because mouse interferon did not induce significant amounts of SAA (J. Sipe, unpublished observations). Future work will determine what relationship SAA inducer has to other mediators ofendotoxicity, such as tumor necrosis factor and GAF.
Summary
The mechanism by which LPS stimulates an acute phase serum amyloid A (SAA) response in C3H mice has been studied. A factor (SAA inducer) appears in the blood of C3H/HeN (iipopolysaccharide [LPS]-sensitive) mice ~ 1 h after administration of LPS, which, when passively administered, can induce C3H/HeJ mice to produce SAA although they are resistant to the LPS itself. SAA inducer has been detected in the culture medium of LPS treated C3H/HeN macrophages but not spleen cells. Thus, two stages in the induction of the acutephase SAA response are now recognized: a latent period of 2-3 h during which the SAA concentration remains at baseline values and in which SAA inducer appears, and the period of synthesis of SAA which lasts for -24 h past induction. It is proposed that a macrophage response to LPS is responsible for production of the serum mediator which induces SAA synthesis.
